Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has awarded two new research grants to support studies on zipalertinib, a promising therapy for Non-Small ...

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

Study compared use of chemotherapy and radiotherapy in 280,000 people from Britain, Australia, Norway and Canada ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Lung cancer surgery is the primary treatment for lung cancer, when possible. Learn about the multiple types of lung cancer surgery, procedures, and associated risks.

McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Many cancer survivors struggle with muscle weakness, which can be so profound that they may have difficulties walking up a ...